Noriko Katagiri

Title: Noriko Katagiri: Innovator in Prostaglandin Measurement

Introduction

Noriko Katagiri is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of medical diagnostics, particularly in the measurement of urinary metabolites. Her innovative approach has the potential to enhance the accuracy and efficiency of diagnostic tests.

Latest Patents

Noriko Katagiri holds a patent for a "Kit and method for measuring prostaglandin E-major urinary metabolite." This patent describes a method that allows for the direct measurement of the prostaglandin E main urinary metabolite (PGE-MUM) from a urine sample treated with alkali. The method eliminates the need for neutralization and dilution, streamlining the immunoassay process. The steps include mixing a urine sample with an alkaline aqueous solution and subjecting the resulting mixture to an immunoassay using a solid phase that is either bicyclo PGE-MUM-immobilized or anti-bicyclo PGE-MUM antibody-immobilized. This innovative method is performed in a weakly-acidic basal buffer solution, enhancing the reliability of the results.

Career Highlights

Noriko Katagiri is associated with Fujirebio Inc., a company known for its advancements in diagnostic technologies. Her work at Fujirebio has focused on developing methods that improve the measurement of important biological markers, contributing to better healthcare outcomes.

Collaborations

Noriko collaborates with Shintaro Yagi, who is also involved in research and development within the same field. Their partnership exemplifies the collaborative spirit in scientific research, leading to innovative solutions in medical diagnostics.

Conclusion

Noriko Katagiri's contributions to the field of prostaglandin measurement highlight her role as an influential inventor. Her patented method represents a significant advancement in diagnostic technology, showcasing her commitment to improving healthcare through innovation.